← 返回

利用 CAR-T 细胞治疗对抗多形性胶质母细胞瘤:过去、现在与未来的发展

英文原题:Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.

查看英文原题

Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.

PubMed 2021/11/26(内容时间) J Neurooncol Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本综述旨在向读者介绍使用 CAR-T 治疗 GBM 的 T 细胞工程领域,并描述为显著延缓 GBM 的持续生长可能需解决的障碍。

研究思路结论见上方概要

多形性胶质母细胞瘤(GBM)是人类最致命的肿瘤之一,尽管它仍被视为一种罕见病。尽管在正在进行的临床试验中测试了多种新的创新疗法,但无论采用何种治疗,这种恶性肿瘤初诊后的中位生存期仍不足两年。一类有前景的新疗法是CAR-T 细胞或CAR-T,已证明其在治疗难治性液体肿瘤(如B细胞恶性肿瘤)方面非常有效。然而,迄今为止,CAR-T 对GBM等实体瘤的疗效仍然有限。

使用嵌合抗原受体或 CAR-T、GBM、实体瘤免疫治疗、免疫治疗和 CAR-T 联合这些术语,对 Pubmed、Google Scholar、Directory of Open Access Journals 和 Web of Science 进行了文献检索,检索发表时间范围为 1987 年 1 月至 2021 年 11 月。

在本综述中,我们呈现了一份用于治疗GBM的CAR-T 细胞综合列表,描述了针对GBM的新的可能的T细胞工程策略,同时向读者简要介绍了这种前沿疗法的起源历史。我们还整理了一份独特的抗GBM CAR-T 列表,包含其特异性蛋白序列及其功能,以及涉及CAR-T 与GBM的临床试验清单。

展开英文摘要原文

A Pubmed, Google Scholar, Directory of Open Access Journals, and Web of Science literature search using the terms chimeric antigen receptor or CAR-T, GBM, solid tumor immunotherapy, immunotherapy, and CAR-T combination was performed for publication dates between January 1987 and November 2021.

In the current review, we present a comprehensive list of CAR-T cells developed to treat GBM, we describe new possible T-cell engineering strategies against GBM while presenting a short introductory history to the reader regarding the origin(s) of this cutting-edge therapy. We have also compiled a unique list of anti-GBM CAR-Ts with their specific protein sequences and their functions as well as an inventory of clinical trials involving CAR-T and GBM.

The aim of this review is to introduce the reader to the field of T-cell engineering using CAR-Ts to treat GBM and describe the obstacles that may need to be addressed in order to significantly delay the relentless growth of GBM.

论文信息

作者
Soler DC、Kerstetter-Fogle A、McCormick TS、Sloan AE
第一作者单位
Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.United States
通讯作者单位
Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. Andrew.Sloan@uhhospitals.org.United States
文献类型
综述
期刊
Journal of neuro-oncology2022 Jan
原文标识
PubMed 34825292 · DOI 10.1007/s11060-021-03902-8